This inventor holds 2 USPTO granted patents. Top assignee: D-Gen Limited. Active years: 2003-2011.
Company Filing History:
Years Active: 2003-2011
Title: Anthony R Clarke: Innovator in Prion Protein Research
Introduction
Anthony R Clarke is a notable inventor based in London, GB. He has made significant contributions to the field of biomedical research, particularly in the area of prion proteins. With a total of 2 patents, Clarke's work focuses on innovative methods for diagnosing and treating diseases related to prion proteins.
Latest Patents
Clarke's latest patents include groundbreaking methods for producing a β-form of prion protein. This form is characterized by a higher β-sheet content compared to the α-helix structure, making it soluble without the need for denaturants. The invention is particularly relevant for medical applications, as it aids in raising antibodies useful for the treatment and diagnosis of prion diseases. Additionally, the patent outlines methods for screening compounds that can inhibit or reverse the conversion of the native α-form of prion protein to the β-form, further emphasizing its potential in medical research.
Career Highlights
Clarke is associated with D-Gen Limited, where he continues to advance his research in prion proteins. His work has garnered attention for its potential impact on understanding and treating prion-related diseases.
Collaborations
Clarke has collaborated with esteemed colleagues such as John Collinge and Graham Stuart Jackson, contributing to a rich environment of innovation and research in his field.
Conclusion
Anthony R Clarke's contributions to prion protein research highlight his role as a significant inventor in the biomedical field. His innovative patents pave the way for advancements in the diagnosis and treatment of prion diseases.